Evidence lacking for widespread use of beta-blockers in CHD

Evidence lacking for widespread use of β-blockers in CHD

(HealthDay)—There is currently insufficient data to support the use of β-blockers for all patients with clinically stable coronary heart disease (SCHD), according to a paper published in the Nov. 15 issue of The American Journal of Cardiology.

David E. Winchester, M.D., and Carl J. Pepine, M.D., from the University of Florida College of Medicine in Gainesville, discuss the use of β-blockers for patients with SCHD.

The researchers note that β-blockers are assumed to be beneficial in SCHD based on older data, established before widespread use of reperfusion interventions, modern medical therapy, or preventive treatments. Their use has been extrapolated beyond patients with failure and previous myocardial infarction, which have the best evidence for efficacy. No from the modern era are available demonstrating that β-blockers reduce clinical events in SCHD. In addition, β-blocker use is not without risk, with use correlating with weight gain, glycemic control problems, fatigue, and bronchospasm.

"In conclusion, data are currently lacking to support the widespread use of β-blockers for all SCHD patients, but contemporary data suggest that they be reserved for a well-defined high-risk group of with evidence of ongoing ischemia, left ventricular dysfunction, , and perhaps some arrhythmias," the authors write.

The development of the manuscript was supported by Gilead Sciences.

Explore further

Beta-blockers have no mortality benefit in post-heart attack patients, say researchers

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: American Journal of Cardiology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Evidence lacking for widespread use of beta-blockers in CHD (2014, November 11) retrieved 19 June 2021 from https://medicalxpress.com/news/2014-11-evidence-lacking-widespread-beta-blockers-chd.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments